• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • Our Services
  • Contact Us
  • Newsletter
  • Top Nav Social Icons

FindBiometrics

FindBiometrics

Global Identity Management

  • Biometrics
    • What are Biometrics?
    • FAQ
    • Biometric Associations
    • Companies
    • Premier Partners
  • News
    • Featured Articles
    • Interviews
    • Thought Leadership
    • Podcasts
    • Webinars
    • Year in Review
  • Applications
    • Biometric Security
    • Border Control and Airport Biometrics
    • Consumer and Residential Biometrics
    • Financial Biometrics
    • Fingerprint & Biometric Locks
    • Healthcare Biometrics
    • Justice and Law Enforcement Biometrics
    • Logical Access Control Biometrics
    • Mobile Biometrics
    • Other Biometric Applications
    • Physical Access Control Biometrics
    • Biometric Time and Attendance
  • Solutions
    • Behavioral Biometrics
    • Biometric Sensors and Detectors
    • Facial Recognition
    • Biometric Fingerprint Readers
    • Hand Readers & Finger Scanners
    • Iris Recognition
    • Biometric Middleware and Software
    • Multimodal Biometrics
    • Physiological Biometrics
    • Smart Cards
    • Vein Recognition
    • Voice and Speech Recognition
  • Stocks
  • Events
  • Companies
  • Podcasts

G42 Healthcare Brings Biometric WHOOP Bands Into COVID-19 Vaccine Trial

August 17, 2020

G42 Healthcare has announced a partnership with Boston-based wearable tech firm WHOOP that will result in volunteers participating in Phase III trials of an inactivated COVID-19 vaccine having the option to wear the WHOOP Strap 3.0 biometric smart band to measure various biometric data points while trialing the vaccine in what is being called The Whoop4Humanity initiative.

G42 Healthcare Brings Biometric WHOOP Bands Into COVID-19 Vaccine Trial

“As a digital business, this new partnership is a logical extension of the highly-advanced AI and super computer solutions we are already using in the trials process,” said G42 Heathcare CEO Ashish Koshy. “New volunteers will be invited to engage with the technology developed by WHOOP to enhance their individual volunteer experience and contribute to the advanced research involved in these sophisticated trials.”

The WHOOP Strap 3.0 will allow trial participants who choose to wear the device to track their daily heart rate, respiratory rate, sleep performance data and more, providing researchers with the biometric data from those metrics which may be valuable to the success of the trial.

“We believe that giving volunteers an opportunity to use the WHOOP Strap 3.0 wearable device will reinforce their confidence in the trial by giving them the ability to check on several daily health data points,” commented Koshy. “This will complement the world-class clinical expertise that the healthcare professionals in the UAE are providing to the volunteers and ensure their safety and well-being throughout the trials process,” he added.

This news comes almost one month after it was announced that the Ladies Professional Golf Association (LPGA) and its European tour partner the Ladies European Tour (LET) were acquiring one thousand WHOOP smart bands to help monitor the vitals of players and personnel on tour.

“WHOOP is proud to partner with G42 Healthcare and participate in their innovative Phase III COVID-19 vaccine trial,” said Will Ahmed, WHOOP Founder & CEO. “The continuous biometric monitoring offered by WHOOP will help volunteers evaluate any changes to their health and help researchers vastly increase their understanding of the vaccine’s impact.”

Ahmed also added that he believes the partnership “represents the future of healthcare: using continuous monitoring and artificial intelligence to better understand the effect of drugs, vaccines, and other treatments.”

G42 Healthcare, a subsidiary of Abu Dhabi-based Group 42, is conducting the clinical trials of the vaccine — which began on July 16th in Abu Dhabi — in partnership with the Department of Health – Abu Dhabi, the UAE Ministry of Health and Prevention (MOHAP) and Abu Dhabi Health Services Company (SEHA).

Phase III — which will last for between six and 12 months — follows two previous successful trials conducted by SinoPharm in China, and is open to individuals between 18 and 60 years of age living in the UAE and Bahrain.

–

August 17, 2020 – by Tony Bitzionis

Related News

  • Biostrap CEO Shares Personal Biometric Data Following Bout With COVID-19Biostrap CEO Shares Personal Biometric Data Following Bout With COVID-19
  • Purdue, PhysIQ to Study Whether Biometric Wearables Can Detect COVID-19Purdue, PhysIQ to Study Whether Biometric Wearables Can Detect COVID-19
  • U.S. Military Turns to Biometric Wearables for Predictive COVID-19 DiagnosisU.S. Military Turns to Biometric Wearables for Predictive COVID-19 Diagnosis
  • Data from Biometric Ring Can Predict Onset of COVID-19, Researchers SayData from Biometric Ring Can Predict Onset of COVID-19, Researchers Say
  • CovIdentify Study Looks to Smartphone, Wearable Biometrics for Symptoms of COVID-19CovIdentify Study Looks to Smartphone, Wearable Biometrics for Symptoms of COVID-19
  • RTHM and Stella Leverage Wearable Biometrics to Help Treat Long COVIDRTHM and Stella Leverage Wearable Biometrics to Help Treat Long COVID

Filed Under: News Tagged With: Biometric, biometric data, biometric sensors, biometric wearables, biometrics, clinical trials, coronavirus, COVID-19, wearable biometrics, wearable tech

Primary Sidebar

EXCLUSIVE MEMBERS ONLY CONTENT:

Become a FindBiometrics Member and gain easy access to specialty content, including the ID Tech column, replays of virtual events, and Identity School educational checklists:

ID Tech: America’s Most Murderous City Reverses Its Facial Recognition Ban [NEW]

ID TECH: What Role Will Biometrics Play in the Cyber Cold War? We’re About to Find Out

Identity School: Facial Recognition Cheat Sheet

Sponsored Links

TECH5 showcase logo

TECH5 is an international technology company founded by experts from the biometrics industry, which focuses on developing disruptive biometric and digital ID solutions through the application of AI and Machine Learning technologies.

TECH5 target markets include both Government and Private sectors with products powering Civil ID, Digital ID, as well as authentication solutions that deliver identity assurance for various use cases. 

Learn more: www.tech5.ai

Onfido logo

Onfido is building the new identity standard for the internet.Our AI-based technology assesses whether a user’s government-issued ID is genuine or fraudulent, and then compares it against their facial biometrics. That’s how we give companies like Revolut, Zipcar and Bitstamp the assurance they need to onboard customers remotely and securely. Our mission is to create a more open world, where identity is the key to access.. For more information, please visit www.onfido.com

ThreatMark brings trust to the digital world by providing cutting-edge fraud prevention solutions. Major banks use ThreatMark’s AI-powered technology and behavioral biometrics to build secured banking experience to precisely verify their legitimate users, seamlessly across all digital channels. All while securing the users’ most precious assets and keeping the fraudsters away. Learn more: www.threatmark.com/

With its secunet border gears product portfolio and specialised consulting expertise, secunet supports police forces and security authorities in their sovereign tasks. Whether ABC gates, self-service kiosks or biometric middleware – each component helps to strengthen identity protection and to accelerate verification – in mobile and stationary scenarios.

Mobile ID World Logo

Mobile ID World is here to bring you the latest in mobile authentication solutions and application providers. Our company is dedicated to providing users with the best content and cutting edge information on technology, news, and mobile solutions for your mobile identity management needs.

Recent Posts

  • Deals, Data Breaches, and Trucker Biometrics: Identity News Digest
  • UK Home Office to Outfit Migrant Criminals With Face-scanning Smartwatches
  • Remote Monitoring and Smart Mailboxes: Identity News Digest
  • NEXT Biometrics’ $2.2M India Deal Is Now ‘Irrevocable’
  • The FTC Wades into the Privacy Discourse: Biometrics News Digest

Biometric Associations

IBIA and fido

Tweets

Footer

  • About Us
  • Company Directory
  • Advertise With Us
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • Archives
  • CCPA: Do not sell my personal info.

Follow Us

Copyright © 2022 FindBiometrics